Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
about
Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug designGenome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, ChinaAldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesionsAKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signalingViral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.Molecular analysis of thymoma.Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling.Low expression of Aldo-keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma.Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10)Antioxidant-rich leaf extract of Barringtonia racemosa significantly alters the in vitro expression of genes encoding enzymes that are involved in methylglyoxal degradation IIIRole of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.Retrospective Proteomic Screening of 100 Breast Cancer Tissues.Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathwayAldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma.Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10.Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.Identification of cytotoxic mediators and their putative role in the signaling pathways during docosahexaenoic acid (DHA)-induced apoptosis of cancer cells.The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.Quantitative proteomic analysis of pancreatic cyst fluid proteins associated with malignancy in intraductal papillary mucinous neoplasms.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy ReactionPrognostic significance of AKR1B10 in patients with resected lung adenocarcinoma
P2860
Q27689445-A35604BE-1ABF-4845-9955-2B6AB9F5F2CEQ28538135-207FD846-5C0D-4AD3-B497-B92644CA413FQ33600379-72BF6A0C-9501-4FF4-B2AC-99E06E8FA0FFQ33648303-3384D7BE-00CD-409D-9239-439D0376ED05Q33779639-816AE642-3665-472D-932C-2912ABB077E4Q34079748-BDC25513-D8B0-4193-91F0-A6285CB36DA8Q34388819-F7394885-BF05-4F2D-9CA2-1A9977958B0DQ35170154-CB73158C-0A1E-41B4-81BB-9F0DEF3C390DQ35655693-6C163132-923B-4AD1-8D88-A5E60A6C3F9DQ36654211-3EB793FF-AAD3-4CA0-96A3-ADDFD9445D4AQ36656870-02C5C4A5-8882-4A32-9F51-1F2817081184Q37151656-DEB8E104-9E32-4F39-A662-E04D0D7EF015Q37234146-A4A049F0-0693-4BCA-8771-3FAEB63235F3Q37617965-FB2F62AE-87F0-4E91-90EB-E7BE27ED5B5BQ37633872-78280883-8E0C-4E79-B74B-FA0FF7909E44Q38689543-35E9AFCD-69B9-43B1-A096-147B9610A653Q38949016-83CFC347-7DE7-4376-9879-8CF2423881C1Q39926530-F6331E21-D029-44DC-8D29-24A932C7F04BQ47148678-E7C86DCA-9D6B-4A0A-8A3D-0F94859ACFD5Q47328769-89485988-D08B-47C8-9D42-DA39EFF0E0C5Q48116483-E50AA400-9042-4A05-AFAC-FA3F3BC22A81Q51430473-7E0BFCDF-4738-4602-AD1E-0712F85C52BCQ52658650-7AD3910D-F074-4607-B349-E6E43FD8A120Q55387536-489ED829-8285-4447-BD2E-2BEA4199E575Q57492406-A5162B1A-F22F-4519-8D24-C46FEFF7D474Q59132360-0437F6C7-4441-47B4-9014-7C1A6A62C671
P2860
Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Overexpression and oncogenic f ...... 1B10) in pancreatic carcinoma.
@en
Overexpression and oncogenic function of aldo-keto reductase family 1B10
@nl
type
label
Overexpression and oncogenic f ...... 1B10) in pancreatic carcinoma.
@en
Overexpression and oncogenic function of aldo-keto reductase family 1B10
@nl
prefLabel
Overexpression and oncogenic f ...... 1B10) in pancreatic carcinoma.
@en
Overexpression and oncogenic function of aldo-keto reductase family 1B10
@nl
P2093
P2860
P1433
P1476
Overexpression and oncogenic f ...... 1B10) in pancreatic carcinoma.
@en
P2093
Guang-Yu Yang
Kristina A Matkowskyj
Wanying Zhang
Yeon Tae Chung
P2860
P2888
P304
P356
10.1038/MODPATHOL.2011.191
P577
2012-01-06T00:00:00Z
P5875
P6179
1036340516